HK1147954A1 - Combination of alpha 7 nicotinic agonists and antipsychotics - Google Patents

Combination of alpha 7 nicotinic agonists and antipsychotics

Info

Publication number
HK1147954A1
HK1147954A1 HK11102160.7A HK11102160A HK1147954A1 HK 1147954 A1 HK1147954 A1 HK 1147954A1 HK 11102160 A HK11102160 A HK 11102160A HK 1147954 A1 HK1147954 A1 HK 1147954A1
Authority
HK
Hong Kong
Prior art keywords
combination
antipsychotics
alpha
nicotinic agonists
nicotinic
Prior art date
Application number
HK11102160.7A
Other languages
English (en)
Inventor
Merouane Bencherif
Gregory J Gatto
Terry Hauser
Kristen G Jordan
Sharon R Letchworth
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Publication of HK1147954A1 publication Critical patent/HK1147954A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
HK11102160.7A 2008-02-13 2011-03-03 Combination of alpha 7 nicotinic agonists and antipsychotics HK1147954A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2828208P 2008-02-13 2008-02-13
PCT/US2009/034062 WO2009102962A2 (fr) 2008-02-13 2009-02-13 Agonistes nicotiniques alpha-7 et antipsychotiques

Publications (1)

Publication Number Publication Date
HK1147954A1 true HK1147954A1 (en) 2011-08-26

Family

ID=40902222

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11102160.7A HK1147954A1 (en) 2008-02-13 2011-03-03 Combination of alpha 7 nicotinic agonists and antipsychotics

Country Status (26)

Country Link
US (1) US20110059947A1 (fr)
EP (2) EP2254598B1 (fr)
JP (1) JP2011511845A (fr)
KR (1) KR20100113163A (fr)
CN (2) CN101977628A (fr)
AU (1) AU2009214625A1 (fr)
BR (1) BRPI0907570A2 (fr)
CA (1) CA2715268A1 (fr)
CO (1) CO6290706A2 (fr)
CY (1) CY1114492T1 (fr)
DK (1) DK2254598T3 (fr)
EC (1) ECSP10010471A (fr)
ES (1) ES2430622T3 (fr)
HK (1) HK1147954A1 (fr)
HR (1) HRP20130749T1 (fr)
IL (1) IL207389A0 (fr)
MX (1) MX2010008875A (fr)
NZ (1) NZ587312A (fr)
PL (1) PL2254598T3 (fr)
PT (1) PT2254598E (fr)
RS (1) RS52941B (fr)
RU (1) RU2481123C2 (fr)
SG (1) SG188144A1 (fr)
SI (1) SI2254598T1 (fr)
WO (1) WO2009102962A2 (fr)
ZA (1) ZA201005999B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
SA08290475B1 (ar) * 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
MX2013003344A (es) 2010-09-23 2013-06-28 Abbvie Inc Monohidrato de un derivado de azaadamantano.
KR20140011320A (ko) * 2011-01-18 2014-01-28 타가셉트 인코포레이티드 정신분열증에서 인지 기능장애의 치료
US9139576B2 (en) 2011-05-03 2015-09-22 Merck Sharp & Dohme Corp. Aminomethyl biaryl benzotriazole derivatives
RU2015116816A (ru) * 2012-10-02 2016-11-27 Сумитомо Дайниппон Фарма Ко., Лтд. Производное имидазола
CA3047451A1 (fr) 2016-12-20 2018-06-28 Lts Lohmann Therapie-Systeme Ag Systeme therapeutique transdermique comportant de l'asenapine
KR102614709B1 (ko) 2016-12-20 2023-12-18 에르테에스 로만 테라피-시스테메 아게 아세나핀 및 폴리실록산 또는 폴리이소부틸렌을 함유하는 경피흡수 치료 시스템
CN108727416B (zh) * 2017-04-20 2021-03-09 北京大学 三环杂芳香体系酰胺衍生物及其制备和用途
BR112019027037B1 (pt) 2017-06-26 2022-04-05 Lts Lohmann Therapie-Systeme Ag Sistema terapêutico transdérmico contendo asenapina e polímero híbrido acrílico de silicone, e processo para fabricar uma camada contendo asenapina para uso no referido sistema
CN107469087A (zh) * 2017-09-10 2017-12-15 孙永丽 用于治疗精神病的制剂
JP7502199B2 (ja) 2018-06-20 2024-06-18 エルテーエス ローマン テラピー-ジステーメ アーゲー アセナピンを含有する経皮治療システム
JP2024502470A (ja) * 2021-01-08 2024-01-19 アイエフエム デュー インコーポレイテッド Sting活性に関連する状態を治療するための化合物および組成物
DE102022114269A1 (de) 2022-06-07 2023-12-07 Rational Aktiengesellschaft Gargerät mit einem Selbstreinigungssystem sowie ein Verfahren zum Ändern von Reinigungsparametern für das Gargerät

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597919A (en) 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5712270A (en) * 1995-11-06 1998-01-27 American Home Products Corporation 2-arylamidothiazole derivatives with CNS activity
US5616716A (en) 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
US5663356A (en) * 1996-04-23 1997-09-02 Ruecroft; Graham Method for preparation of aryl substituted alefinic secondary amino compounds
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
PT1083889E (pt) 1998-06-01 2004-04-30 Ortho Mcneil Pharm Inc Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas
US6953855B2 (en) * 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
SE9904176D0 (sv) 1999-11-18 1999-11-18 Astra Ab New use
WO2001041750A2 (fr) * 1999-12-10 2001-06-14 Wyeth Nouvelles combinaisons therapeutiques de (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-one et neuroleptiques destines au traitement ou a la prevention de troubles psychotiques
PL201530B1 (pl) * 2000-06-27 2009-04-30 L V A T Lab Sa Karbaminiany pochodne aryloalkiloamin i zastosowanie karbaminianów pochodnych aryloalkiloamin
US6492386B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
WO2002016357A2 (fr) 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Composes aryle substitues par quinuclidine destines au traitement de maladies
EP1381603A2 (fr) 2000-08-18 2004-01-21 PHARMACIA & UPJOHN COMPANY Composes aryliques substitues par quinuclidine destines au traitement de maladies (ligands du recepteur nicotinique de l'acetylcholine)
JP2004506734A (ja) 2000-08-21 2004-03-04 ファルマシア・アンド・アップジョン・カンパニー 疾患治療用のキヌクリド置換ヘテロアリール部分
AU2001282875A1 (en) 2000-08-21 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6599916B2 (en) 2000-08-21 2003-07-29 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6554086B1 (en) * 2000-10-27 2003-04-29 Invacare Corporation Obstacle traversing wheelchair
KR100869722B1 (ko) 2000-12-22 2008-11-21 알미랄 에이쥐 퀴누클리딘 카르바메이트 유도체 및 m3 길항제로서 그의사용
US6894042B2 (en) * 2002-02-19 2005-05-17 Pharmacia & Upjohn Company Azabicyclic compounds for the treatment of disease
AU2003302911A1 (en) * 2002-12-06 2004-06-30 Pharmacia & Upjohn Company Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compostions and preparations thereof
TW200502222A (en) * 2003-04-02 2005-01-16 Novartis Ag Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders
WO2004099202A1 (fr) * 2003-05-05 2004-11-18 Pharmacia & Upjohn Company Llc Carboxamides de benzodioxine substitues par des quinuclidines pour le traitement de maladies neurodegeneratives
US7309699B2 (en) * 2003-12-22 2007-12-18 Abbott Laboratories 3-Quinuclidinyl amino-substituted biaryl derivatives
JP2007516275A (ja) * 2003-12-23 2007-06-21 ファイザー・プロダクツ・インク 認知増強および精神病性障害のための治療的組合せ
CA2601509A1 (fr) * 2005-03-18 2006-09-28 Abbott Laboratories Ligand du recepteur nicotinique neuronal alpha7 et compositions antipsychotiques

Also Published As

Publication number Publication date
EP2633868A1 (fr) 2013-09-04
SG188144A1 (en) 2013-03-28
CN103143023A (zh) 2013-06-12
CO6290706A2 (es) 2011-06-20
HRP20130749T1 (en) 2013-10-11
KR20100113163A (ko) 2010-10-20
EP2254598A2 (fr) 2010-12-01
US20110059947A1 (en) 2011-03-10
CY1114492T1 (el) 2016-10-05
PL2254598T3 (pl) 2013-12-31
CN101977628A (zh) 2011-02-16
BRPI0907570A2 (pt) 2019-09-24
RS52941B (en) 2014-02-28
SI2254598T1 (sl) 2013-10-30
WO2009102962A3 (fr) 2009-10-08
DK2254598T3 (da) 2013-07-29
IL207389A0 (en) 2010-12-30
NZ587312A (en) 2011-12-22
ECSP10010471A (es) 2010-10-30
RU2010137787A (ru) 2012-03-20
JP2011511845A (ja) 2011-04-14
AU2009214625A1 (en) 2009-08-20
ES2430622T3 (es) 2013-11-21
ZA201005999B (en) 2011-05-25
WO2009102962A2 (fr) 2009-08-20
RU2481123C2 (ru) 2013-05-10
PT2254598E (pt) 2013-10-16
CA2715268A1 (fr) 2009-08-20
EP2254598B1 (fr) 2013-07-10
MX2010008875A (es) 2010-08-31

Similar Documents

Publication Publication Date Title
HK1147954A1 (en) Combination of alpha 7 nicotinic agonists and antipsychotics
HRP20130713T1 (en) Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics
IL196355A0 (en) Ep2 agonists
EP2244639A4 (fr) Bioagrafes appropriées pour des remplacements ou des réparations de ligament du poignet, de la main et d'autres ligaments
HK1140968A1 (fr)
SG171584A1 (en) Nanoparticulate metal boride composition and its use for identification- marking plastic parts
IL184324A0 (en) Pyy agonists and uses thereof
EP1942905A4 (fr) Agonistes des recepteurs de l'acide nicotinique, compositions contenant ces composes et methodes de traitement
IL184535A0 (en) Peracid/peroxide composition and use thereof as an anti-microbial and photosensitizer
EP2094118A4 (fr) Composition amelioree d'acide peracetique
EP2346906A4 (fr) Conjugués d'agonistes de glp-1 et leurs utilisations
EP1874301A4 (fr) Agonistes du recepteur de la niacine, compositions les contenant et methodes de traitement
IL188329A0 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
MX2012006931A (es) Componente de articulo para fumar.
EP1971602A4 (fr) Agonistes du recepteur de la niacine, compositions contenant de tels composes et procedes de traitement
ZA200804915B (en) Benzimidazole non-aqueous compositions
EP1940402A4 (fr) Agonistes du recepteur de l'acide nicotinique, compositions contenant ces composes et methodes de traitement
IL184768A0 (en) Controlled release compositions comprising an antipsychotic agent
IL190045A0 (en) Use of c3-c10 17 alfa-esters of 9,11-dehydrocortexolone as anti-gonadotrophic agents
GB0516439D0 (en) EP2 receptor agonists
GB2429656B (en) Cue tip shaper
UA60035U (ru) Состав для лечения генерализованного пародонтита
SI2134330T1 (sl) Kombinacije 5-HT2A inverznih agonistov in antagonistov z antipsihotiki
UA41095U (ru) Состав для защиты металлов от коррозии
GB0519873D0 (en) PPAR Agonists I

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170213